🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Cellectar Biosciences, Inc. (CLRB)
NASDAQ: CLRB · Real-Time Price · USD
0.8852
-0.0351 (-3.81%)
At close: Nov 18, 2026, 4:00 PM EST
0.8853
+0.0001 (0.01%)
After-hours: Nov 18, 2026, 6:09 PM EST

Cellectar Biosciences Statistics

Total Valuation

CLRB has a market cap or net worth of $8.89 million. The enterprise value is -$14.16 million.

Market Cap8.89M
Enterprise Value -14.16M

Important Dates

The last earnings date was Tuesday, November 10, 2026, before market open.

Earnings Date Nov 10, 2026
Ex-Dividend Date n/a

Share Statistics

CLRB has 10.04 million shares outstanding. The number of shares has increased by 394.50% in one year.

Current Share Class 10.04M
Shares Outstanding 10.04M
Shares Change (YoY) +394.50%
Shares Change (QoQ) +42.77%
Owned by Insiders (%) 1.73%
Owned by Institutions (%) 33.03%
Float 7.57M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.40
P/TBV Ratio 0.40
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 4.44, with a Debt / Equity ratio of 0.07.

Current Ratio 4.44
Quick Ratio 4.24
Debt / Equity 0.07
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -162.63% and return on invested capital (ROIC) is -99.18%.

Return on Equity (ROE) -162.63%
Return on Assets (ROA) -75.46%
Return on Invested Capital (ROIC) -99.18%
Return on Capital Employed (ROCE) -111.86%
Weighted Average Cost of Capital (WACC) 6.57%
Revenue Per Employee n/a
Profits Per Employee -$2.35M
Employee Count11
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -69.68% in the last 52 weeks. The beta is 0.63, so CLRB's price volatility has been lower than the market average.

Beta (5Y) 0.63
52-Week Price Change -69.68%
50-Day Moving Average 1.54
200-Day Moving Average 2.48
Relative Strength Index (RSI) 25.05
Average Volume (20 Days) 87,642

Short Selling Information

The latest short interest is 218,774, so 2.18% of the outstanding shares have been sold short.

Short Interest 218,774
Short Previous Month 263,517
Short % of Shares Out 2.18%
Short % of Float 2.89%
Short Ratio (days to cover) 1.35

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -26.78M
Pretax Income -25.85M
Net Income -25.85M
EBITDA -26.63M
EBIT -26.78M
Earnings Per Share (EPS) -$2.71
Full Income Statement

Balance Sheet

The company has $24.58 million in cash and $1.53 million in debt, with a net cash position of $23.05 million or $2.30 per share.

Cash & Cash Equivalents 24.58M
Total Debt 1.53M
Net Cash 23.05M
Net Cash Per Share $2.30
Equity (Book Value) 22.42M
Book Value Per Share 2.23
Working Capital 19.92M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$24.61 million and capital expenditures -$9,258, giving a free cash flow of -$24.62 million.

Operating Cash Flow -24.61M
Capital Expenditures -9,258
Depreciation & Amortization 155,268
Net Borrowing n/a
Free Cash Flow -24.62M
FCF Per Share -$2.45
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

CLRB does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -394.50%
Shareholder Yield -394.50%
Earnings Yield -305.93%
FCF Yield -277.06%

Analyst Forecast

The average price target for CLRB is $11.50, which is 1,199.14% higher than the current price. The consensus rating is "Strong Buy".

Price Target $11.50
Price Target Difference 1,199.14%
Analyst Consensus Strong Buy
Analyst Count 4
Revenue Growth Forecast (3Y) n/a
EPS Growth Forecast (3Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

The last stock split was on June 24, 2025. It was a reverse split with a ratio of 1:30.

Last Split Date Jun 24, 2025
Split Type Reverse
Split Ratio 1:30

Scores

Altman Z-Score n/a
Piotroski F-Score 2